AF
ONCY

Allworth Financial’s Oncolytics Biotech ONCY Stock Holding History

Allworth Financial’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.17K Hold
8,452
– – ﹤0.01% 3732
2025
Q4 		$7.39K Hold
8,452
– – ﹤0.01% 3472
2025
Q3 		$11.8K Hold
8,452
– – ﹤0.01% 3034
2025
Q2 		$6.53K Hold
8,452
– – ﹤0.01% 3117
2025
Q1 		$4.93K Hold
8,452
– – ﹤0.01% 2767
2024
Q4 		$7.44K Buy
8,452
+6,452
+323% +$6.71K ﹤0.01% 2578
2024
Q3 		$1.74K Hold
2,000
– – ﹤0.01% 3020
2024
Q2 		$2.06K Buy
+2,000
New +$2.18K ﹤0.01% 2908

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Allworth Financial's ONCY Position: Q1 2026 in Review

Allworth Financial held its Oncolytics Biotech (ONCY) position steady in Q1 2026 at 8,452 shares worth $7.17K. The position accounts for ﹤0.01% of the portfolio, ranked #3732.

Allworth Financial first reported a position in ONCY in Q2 2024 and has held it in 8 quarters since. The position peaked at $11.8K in Q3 2025. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

  • Allworth Financial held 8,452 shares of Oncolytics Biotech worth $7.17K as of Q1 2026.
  • Allworth Financial left its Oncolytics Biotech share count unchanged in Q1 2026.
  • Oncolytics Biotech made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #3732 holding.
  • Allworth Financial first reported a position in Oncolytics Biotech in Q2 2024 and has held it in 8 quarters since.
  • Allworth Financial's Oncolytics Biotech position peaked at $11.8K in Q3 2025.
  • 59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.